Biopharma’s Prospects Under A Second Trump Term: They Can’t Get Much Worse

 
• By Cathy Kelly
Trump flag
How would Trump's return to the White House impact pharma? • Source: Shutterstock

More from Pink Sheet Perspectives

More from Pink Sheet